Marplan: Uses, Side Effects, Warnings & Dosage

Introduction to Marplan

Marplan (isocarboxazid) is a prescription medication used to treat depression. It belongs to a class of drugs known as monoamine oxidase inhibitors (MAOIs). Marplan works by increasing the levels of certain chemicals in the brain, such as serotonin, dopamine, and norepinephrine, which help regulate mood. This antidepressant has been used for decades and remains a viable treatment option for patients who have not responded well to other medications.

Chemical Composition

The active ingredient in Marplan is isocarboxazid, a non-selective and irreversible MAOI. Isocarboxazid belongs to the hydrazine class of MAOIs and is available as an oral tablet. Its chemical structure is C ₁₂H ₁₃N ₃O ₂, and it has a molecular weight of 231.25 g/mol Isocarboxazid” target=”_blank”>[1].

Mechanism of Action

Marplan acts as a non-selective and irreversible inhibitor of monoamine oxidase, an enzyme responsible for breaking down neurotransmitters such as serotonin, dopamine, and norepinephrine. By inhibiting this enzyme, Marplan increases the availability of these neurotransmitters in the brain, which can help alleviate symptoms of depression [2].

Uses of Marplan

Marplan is primarily used to treat major depressive disorder in adults. It may be prescribed when other antidepressants have failed to provide adequate relief or when a patient cannot tolerate the side effects of other medications. In some cases, Marplan may be used off-label to treat other mental health conditions, such as anxiety disorders or phobias [3].

Dosage and Administration

The recommended starting dosage for Marplan is 10 mg twice daily. The dosage may be gradually increased by 10 mg per day every 2 to 4 days until a therapeutic response is achieved or side effects become intolerable. The maximum recommended dosage is 60 mg per day. Patients should be closely monitored during treatment initiation and dosage adjustments [3].

Side Effects and Warnings

Common side effects of Marplan include dry mouth, constipation, dizziness, headache, and insomnia. More serious side effects may include hypertensive crisis, serotonin syndrome, and liver toxicity. Patients should be cautioned about the potential for severe interactions with certain foods and medications, such as tyramine-rich foods, sympathomimetic drugs, and serotonergic agents [4].

Interactions with Other Medications

Marplan can interact with many medications, including other antidepressants, sympathomimetic drugs, opioids, and certain herbal supplements. Patients should inform their healthcare provider about all medications and supplements they are taking before starting Marplan. Alcohol and tyramine-rich foods should be avoided during treatment due to the risk of hypertensive crisis [4].

Contraindications

Marplan is contraindicated in patients with a history of hypersensitivity to isocarboxazid or any component of the formulation. It should not be used in patients with pheochromocytoma, cardiovascular disease, cerebrovascular disease, or liver disease. Marplan is also contraindicated in combination with serotonergic drugs, sympathomimetic agents, and opioids [3].

Precautions and Monitoring

Patients taking Marplan should be closely monitored for signs of hypertensive crisis, serotonin syndrome, and liver toxicity. Blood pressure should be checked regularly, and liver function tests should be performed periodically. Patients should be educated about the signs and symptoms of these potentially life-threatening conditions and instructed to seek immediate medical attention if they occur [4].

armacokinetics”> armacokinetics/”>Ph armacokinetics

Isocarboxazid is rapidly absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 2 to 4 hours. It is extensively metabolized in the liver and has a half-life of approximately 36 hours. Isocarboxazid is primarily excreted in the urine as metabolites, with small amounts excreted in the feces [3].

Efficacy in Treating Depression

Several studies have demonstrated the efficacy of Marplan in treating depression. A meta-analysis of randomized controlled trials found that MAOIs, including Marplan, were more effective than placebo in treating depressive disorders [5]. However, the use of MAOIs has declined in recent years due to the availability of newer antidepressants with more favorable side effect profiles.

Patient Information and Counseling

Patients should be counseled on the proper use of Marplan, including the importance of taking the medication as prescribed and not altering the dosage without consulting their healthcare provider. They should be informed about potential side effects and the signs and symptoms of hypertensive crisis and serotonin syndrome. Patients should also be educated about dietary restrictions and the need to avoid certain medications and supplements while taking Marplan.

Brand and Generic Availability

Marplan is available as a brand-name drug manufactured by Validus armaceutical/”>Ph armaceuticals LLC. Generic versions of isocarboxazid are also available from various manufacturers. The brand name Marplan is also known as Marplon and Enerzer in some countries [6].

Regulatory and Approval History

Marplan was first approved by the U.S. Food and Drug Administration (FDA) in 1959 for the treatment of depression. Over the years, the labeling has been updated to include warnings about potential interactions and side effects. In 2017, the FDA approved an updated labeling for Marplan, which includes a boxed warning about the risk of hypertensive crisis and serotonin syndrome [3].

Practical Information for Healthcare Providers

Healthcare providers should be familiar with the indications, dosing, and potential side effects of Marplan. They should carefully screen patients for contraindications and monitor them closely during treatment for signs of adverse reactions. Providers should also educate patients about dietary restrictions and the need to avoid certain medications and supplements while taking Marplan [4].

Patient Support and Resources

Patients taking Marplan may benefit from support groups and counseling to help manage their depression and cope with the challenges of treatment. The National Alliance on Mental Illness (NAMI) provides resources and support for individuals with mental health conditions and their families. The Depression and Bipolar Support Alliance (DBSA) also offers peer support and educational resources for those with mood disorders.

Future Directions and Research

While the use of MAOIs like Marplan has declined in recent years, ongoing research continues to explore their potential benefits and risks. Some studies have investigated the use of MAOIs in combination with other antidepressants or in the treatment of specific populations, such as older adults or those with treatment-resistant depression [7].

Marplan in Context

Marplan belongs to an older class of antidepressants known as MAOIs, which were among the first medications used to treat depression. While MAOIs are still considered effective, they have largely been replaced by newer antidepressants, such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), which have more favorable side effect profiles and fewer dietary restrictions. However, Marplan remains a viable treatment option for some patients, particularly those who have not responded adequately to other antidepressants.